Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge news about newly diagnosed breast cancer including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Women With Young Children Less Likely to Receive Radiation Therapy

Having very young children may affect whether women receive radiation therapy after breast-conserving surgery.

ASCO Releases Updated Sentinel Lymph Node Biopsy Guidelines

The American Society of Clinical Oncology published updates to their 2005 guidelines for use of sentinel lymph node biopsy in early-stage breast cancer. The guidelines, based on the review of 9 randomized clinical trials and 13 cohort studies, reflect what ASCO believes are best practices in using the biopsy.

After Some Breast Cancer Treatments, Risk for Other Health Conditions May Rise

A recent study suggests that while women are living longer after treatment for breast cancer, they may be at greater risk of developing certain health conditions as they age.

After Mastectomy, More Women Choosing Breast Reconstruction

More and more women are choosing breast reconstruction following mastectomy, partially due to the considerable rise in use of bilateral mastectomy.

Most Not Preserving Fertility Before Breast Cancer Treatment

Although concerned about how breast cancer treatment might affect their future ability to have children, few young women take steps to preserve fertility before treatment.

Yoga May Lower Fatigue, Inflammation After Breast Cancer Treatment

According to a study recently published in the Journal of Clinical Oncology, practicing Hatha yoga for as few as 3 months may lessen fatigue and inflammation in people treated for breast cancer.

Physical Activity After Breast Cancer May Improve Quality of Life

Exercising often after breast cancer treatment ends may help women improve their quality of life over time, say researchers from the University of Illinois at Urbana-Champaign.

More Pre-Surgery Trastuzumab Not More Effective

Researchers found the same amount of tumor cells present at surgery among two groups of women receiving therapy for HER2-positive breast cancer. The first group was treated before surgery with trastuzumab (Herceptin) plus paclitaxel (Taxol), followed by anthracycline chemotherapy. The second received the same treatment, but with more trastuzumab given at the same time as the anthracycline. This finding lends support to past studies showing trastuzumab is not needed during anthracycline (e.g., doxorubicin or epirubicin) treatment to shrink or get rid of the cancer before surgery.

Tailored Treatment Based on Response to Early Chemotherapy May Improve Survival in Early-Stage Disease

Researchers who observed whether a tumor shrank after the first few cycles of pre-surgery, or neoadjuvant, chemotherapy made an important observation. They found that when they based further chemotherapy treatment on the tumor’s reaction, outcomes were best for women with hormone receptor-positive breast cancer. These women lived for the longest spans of time without the cancer growing or traveling, compared with women with tumors testing negative for hormones.  

Study Compares Survival Rates of Women After Lumpectomy, Mastectomy

Women with early-stage breast cancer treated with lumpectomy followed by radiation may live longer than those receiving mastectomy alone or with radiation, researchers found.Their study, published in the journal JAMA Surgery, compared the risk of dying from breast cancer over 10 years.

Denver, CO  ·  September 13, 2014

Join Your Community for Yoga on the Steps!

Close
close